Stock Watch: J&J And Roche Invite Comparison
Early Q1 Earnings Reports Highlight Challenges And Green Shoots
Executive Summary
Recovering pharmaceutical and medical device revenues at J&J hint at the green shoots germinating from the pandemic. Roche’s COVID-19 diagnostics revenue growth was its own green shoot, but can these be maintained as the pandemic evolves?